1. Kuroda S, Houkin K. Moyamoya disease: current concepts and future perspectives. Lancet Neurol. 2008; 7:1056–1066. PMID:
18940695.
2. Suzuki J, Kodama N. Moyamoya disease--a review. Stroke. 1983; 14:104–109. PMID:
6823678.
3. Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis. Health Labour Sciences Research Grant for Research on Measures for Infractable Diseases. Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis). Neurol Med Chir (Tokyo). 2012; 52:245–266. PMID:
22870528.
4. Yun TJ, Cheon JE, Na DG, Kim WS, Kim IO, Chang KH, et al. Childhood moyamoya disease: quantitative evaluation of perfusion MR imaging--correlation with clinical outcome after revascularization surgery. Radiology. 2009; 251:216–223. PMID:
19332853.
5. Kim T, Oh CW, Bang JS, Kim JE, Cho WS. Moyamoya disease: treatment and outcomes. J Stroke. 2016; 18:21–30. PMID:
26846757.
6. Matsushima T, Inoue T, Suzuki SO, Fujii K, Fukui M, Hasuo K. Surgical treatment of moyamoya disease in pediatric patients--comparison between the results of indirect and direct revascularization procedures. Neurosurgery. 1992; 31:401–405. PMID:
1407421.
7. Patel NN, Mangano FT, Klimo P Jr. Indirect revascularization techniques for treating moyamoya disease. Neurosurg Clin N Am. 2010; 21:553–563. PMID:
20561503.
8. Park JH, Yang SY, Chung YN, Kim JE, Kim SK, Han DH, et al. Modified encephaloduroarteriosynangiosis with bifrontal encephalogaleoperiosteal synangiosis for the treatment of pediatric moyamoya disease. Technical note. J Neurosurg. 2007; 106:237–242. PMID:
17465392.
9. Hasuo K, Tamura S, Kudo S, Uchino A, Carlos R, Matsushima T, et al. Moya moya disease: use of digital subtraction angiography in its diagnosis. Radiology. 1985; 157:107–111. PMID:
3898215.
10. Calamante F, Ganesan V, Kirkham FJ, Jan W, Chong WK, Gadian DG, et al. MR perfusion imaging in moyamoya syndrome: potential implications for clinical evaluation of occlusive cerebrovascular disease. Stroke. 2001; 32:2810–2816. PMID:
11739978.
11. Tibussek D, Rademacher C, Caspers J, Turowski B, Schaper J, Antoch G, et al. Gadolinium brain deposition after macrocyclic gadolinium administration: a pediatric case-control study. Radiology. 2017; 285:223–230. PMID:
28640695.
12. Mithal LB, Patel PS, Mithal D, Palac HL, Rozenfeld MN. Use of gadolinium-based magnetic resonance imaging contrast agents and awareness of brain gadolinium deposition among pediatric providers in North America. Pediatr Radiol. 2017; 47:657–664. PMID:
28283727.
13. Zhang J, Wang J, Geng D, Li Y, Song D, Gu Y. Whole-brain CT perfusion and CT angiography assessment of moyamoya disease before and after surgical revascularization: preliminary study with 256-slice CT. PLoS One. 2013; 8:e57595. PMID:
23451248.
14. Proisy M, Bruneau B, Rozel C, Tréguier C, Chouklati K, Riffaud L, et al. Arterial spin labeling in clinical pediatric imaging. Diagn Interv Imaging. 2016; 97:151–158. PMID:
26456912.
15. Haller S, Zaharchuk G, Thomas DL, Lovblad KO, Barkhof F, Golay X. Arterial spin labeling perfusion of the brain: emerging clinical applications. Radiology. 2016; 281:337–356. PMID:
27755938.
16. Sugino T, Mikami T, Miyata K, Suzuki K, Houkin K, Mikuni N. Arterial spin-labeling magnetic resonance imaging after revascularization of moyamoya disease. J Stroke Cerebrovasc Dis. 2013; 22:811–816. PMID:
22721824.
17. Zaharchuk G, Do HM, Marks MP, Rosenberg J, Moseley ME, Steinberg GK. Arterial spin-labeling MRI can identify the presence and intensity of collateral perfusion in patients with moyamoya disease. Stroke. 2011; 42:2485–2491. PMID:
21799169.
18. Hara S, Tanaka Y, Ueda Y, Hayashi S, Inaji M, Ishiwata K, et al. Noninvasive evaluation of CBF and perfusion delay of moyamoya disease using arterial spin-labeling MRI with multiple postlabeling delays: comparison with 15O-Gas PET and DSC-MRI. AJNR Am J Neuroradiol. 2017; 38:696–702. PMID:
28209582.
19. Wang R, Yu S, Alger JR, Zuo Z, Chen J, Wang R, et al. Multi-delay arterial spin labeling perfusion MRI in moyamoya disease--comparison with CT perfusion imaging. Eur Radiol. 2014; 24:1135–1144. PMID:
24557051.
20. Goetti R, O'Gorman R, Khan N, Kellenberger CJ, Scheer I. Arterial spin labelling MRI for assessment of cerebral perfusion in children with moyamoya disease: comparison with dynamic susceptibility contrast MRI. Neuroradiology. 2013; 55:639–647. PMID:
23404242.
21. Matsushima T, Fujiwara S, Nagata S, Fujii K, Fukui M, Kitamura K, et al. Surgical treatment for paediatric patients with moyamoya disease by indirect revascularization procedures (EDAS, EMS, EMAS). Acta Neurochir (Wien). 1989; 98:135–140. PMID:
2741743.
22. Wu WC, Fernández-Seara M, Detre JA, Wehrli FW, Wang J. A theoretical and experimental investigation of the tagging efficiency of pseudocontinuous arterial spin labeling. Magn Reson Med. 2007; 58:1020–1027. PMID:
17969096.
23. Wang J, Zhang Y, Wolf RL, Roc AC, Alsop DC, Detre JA. Amplitude-modulated continuous arterial spin-labeling 3.0-T perfusion MR imaging with a single coil: feasibility study. Radiology. 2005; 235:218–228. PMID:
15716390.
24. Wang Z, Aguirre GK, Rao H, Wang J, Fernández-Seara MA, Childress AR, et al. Empirical optimization of ASL data analysis using an ASL data processing toolbox: ASLtbx. Magn Reson Imaging. 2008; 26:261–269. PMID:
17826940.
25. Tatu L, Moulin T, Bogousslavsky J, Duvernoy H. Arterial territories of the human brain: cerebral hemispheres. Neurology. 1998; 50:1699–1708. PMID:
9633714.
26. Robertson RL, Burrows PE, Barnes PD, Robson CD, Poussaint TY, Scott RM. Angiographic changes after pial synangiosis in childhood moyamoya disease. AJNR Am J Neuroradiol. 1997; 18:837–845. PMID:
9159360.
27. Houkin K, Nakayama N, Kuroda S, Ishikawa T, Nonaka T. How does angiogenesis develop in pediatric moyamoya disease after surgery? A prospective study with MR angiography. Childs Nerv Syst. 2004; 20:734–741. PMID:
15197570.
28. Kim SK, Seol HJ, Cho BK, Hwang YS, Lee DS, Wang KC. Moyamoya disease among young patients: its aggressive clinical course and the role of active surgical treatment. Neurosurgery. 2004; 54:840–844. discussion 844-846. PMID:
15046649.
29. Yoon HK, Shin HJ, Lee M, Byun HS, Na DG, Han BK. MR angiography of moyamoya disease before and after encephal oduroarteriosynangiosis. AJR Am J Roentgenol. 2000; 174:195–200. PMID:
10628478.
30. So Y, Lee HY, Kim SK, Lee JS, Wang KC, Cho BK, et al. Prediction of the clinical outcome of pediatric moyamoya disease with postoperative basal/acetazolamide stress brain perfusion SPECT after revascularization surgery. Stroke. 2005; 36:1485–1489. PMID:
15947261.
31. Ikezaki K, Matsushima T, Kuwabara Y, Suzuki SO, Nomura T, Fukui M. Cerebral circulation and oxygen metabolism in childhood moyamoya disease: a perioperative positron emission tomography study. J Neurosurg. 1994; 81:843–850. PMID:
7965114.
32. Saida T, Masumoto T, Nakai Y, Shiigai M, Matsumura A, Minami M. Moyamoya disease: evaluation of postoperative revascularization using multiphase selective arterial spin labeling MRI. J Comput Assist Tomogr. 2012; 36:143–149. PMID:
22261785.
33. Yun TJ, Paeng JC, Sohn CH, Kim JE, Kang HS, Yoon BW, et al. Monitoring cerebrovascular reactivity through the use of arterial spin labeling in patients with moyamoya disease. Radiology. 2016; 278:205–213. PMID:
26197057.
34. Goetti R, Warnock G, Kuhn FP, Guggenberger R, O'Gorman R, Buck A, et al. Quantitative cerebral perfusion imaging in children and young adults with moyamoya disease: comparison of arterial spin-labeling-MRI and H2[15O]-PET. AJNR Am J Neuroradiol. 2014; 35:1022–1028. PMID:
24335546.
35. Blauwblomme T, Lemaitre H, Naggara O, Calmon R, Kossorotoff M, Bourgeois M, et al. Cerebral blood flow improvement after indirect revascularization for pediatric moyamoya disease: a statistical analysis of arterial spin-labeling MRI. AJNR Am J Neuroradiol. 2016; 37:706–712. PMID:
26585258.
36. Lee S, Yun TJ, Yoo RE, Yoon BW, Kang KM, Choi SH, et al. Monitoring cerebral perfusion changes after revascularization in patients with moyamoya disease by using arterial spin-labeling MR imaging. Radiology. 2018; 288:565–572. PMID:
29714677.
37. Lee M, Zaharchuk G, Guzman R, Achrol A, Bell-Stephens T, Steinberg GK. Quantitative hemodynamic studies in moyamoya disease: a review. Neurosurg Focus. 2009; 26:E5.
38. Roach BA, Donahue MJ, Davis LT, Faraco CC, Arteaga D, Chen SC, et al. Interrogating the functional correlates of collateralization in patients with intracranial stenosis using multimodal hemodynamic imaging. AJNR Am J Neuroradiol. 2016; 37:1132–1138. PMID:
27056428.
39. Yoo RE, Yun TJ, Rhim JH, Yoon BW, Kang KM, Choi SH, et al. Bright vessel appearance on arterial spin labeling MRI for localizing arterial occlusion in acute ischemic stroke. Stroke. 2015; 46:564–567. PMID:
25523057.
40. Harreld JH, Helton KJ, Kaddoum RN, Reddick WE, Li Y, Glass JO, et al. The effects of propofol on cerebral perfusion MRI in children. Neuroradiology. 2013; 55:1049–1056. PMID:
23673874.